Ketamine for Depression-Knowns, Unknowns, Possibilities, Barriers, and Opportunities

被引：10

作者：

Andrade, Chittaranjan ^{[1
,2
]}

机构：

[1] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychopharmacol & Neurotoxicol, Bangalore, India

[2] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychopharmacol & Neurotoxicol, Hosur Rd, Bangalore 560029, Karnataka, India

来源：

JAMA PSYCHIATRY | 2023年 / 80卷 / 12期

关键词：

INTRAVENOUS KETAMINE;

D O I：

10.1001/jamapsychiatry.2023.3982

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This Viewpoint discusses ketamine and its new and experimentally investigated on- and off-label indications that span different medical disciplines.

引用

页码：1189 / 1190

页数：2

共 9 条

[1] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression [J].

Anand, A. ;

Mathew, S. J. ;

Sanacora, G. ;

Murrough, J. W. ;

Goes, F. S. ;

Altinay, M. ;

Aloysi, A. S. ;

Asghar-Ali, A. A. ;

Barnett, B. S. ;

Chang, L. C. ;

Collins, K. A. ;

Costi, S. ;

Iqbal, S. ;

Jha, M. K. ;

Krishnan, K. ;

Malone, D. A. ;

Nikayin, S. ;

Nissen, S. E. ;

Ostroff, R. B. ;

Reti, I. M. ;

Wilkinson, S. T. ;

Wolski, K. ;

Hu, B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25) :2315-2325

[2] Oral Ketamine for Depression, 2: Practical Considerations [J].

Andrade, Chittaranjan .

JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (02)

[3] Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT) [J].

Ekstrand, Joakim ;

Fattah, Christian ;

Persson, Marcus ;

Cheng, Tony ;

Nordanskog, Pia ;

Akeson, Jonas ;

Tingstrom, Anders ;

Lindstrom, Mats B. ;

Nordenskjold, Axel ;

Rad, Pouya Movahed .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (05) :339-349

[4] The efficacy of oral ketamine in severely depressed patients at high risk of suicide [J].

Kaur, Saswinder ;

Parmar, Chirag ;

Gaur, Vikas ;

Chauhan, Ajay ;

Andrade, Chittaranjan .

ASIAN JOURNAL OF PSYCHIATRY, 2023, 86

[5] A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009-January 2019 [J].

Marcantoni, Walter S. ;

Akoumba, Bertine Sandra ;

Wassef, Maggy ;

Mayrand, Julie ;

Lai, Hinatea ;

Richard-Devantoy, Stephane ;

Beauchamp, Sylvie .

JOURNAL OF AFFECTIVE DISORDERS, 2020, 277 :831-841

[6] Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode A Systematic Review and Meta-analysis [J].

Rhee, Taeho Greg ;

Shim, Sung Ryul ;

Forester, Brent P. ;

Nierenberg, Andrew A. ;

McIntyre, Roger S. ;

Papakostas, George, I ;

Krystal, John H. ;

Sanacora, Gerard ;

Wilkinson, Samuel T. .

JAMA PSYCHIATRY, 2022, 79 (12) :1162-1172

[7] Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review [J].

Walsh, Zach ;

Mollaahmetoglu, Ozden Merve ;

Rootman, Joseph ;

Golsof, Shannon ;

Keeler, Johanna ;

Marsh, Beth ;

Nutt, David J. ;

Morgan, Celia J. A. .

BJPSYCH OPEN, 2021, 8 (01)

[8] Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms [J].

Wlodarczyk, Adam ;

Dywel, Alicja ;

Cubala, Wieslaw Jerzy .

PHARMACEUTICALS, 2023, 16 (02)

[9] The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis [J].

Xiong, Jiaqi ;

Lipsitz, Orly ;

Chen-Li, David ;

Rosenblat, Joshua D. ;

Rodrigues, Nelson B. ;

Carvalho, Isabelle ;

Lui, Leanna M. W. ;

Gill, Hartej ;

Narsi, Flora ;

Mansur, Rodrigo B. ;

Lee, Yena ;

McIntyre, Roger S. .

JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 134 :57-68

← 1 →